1Fouilloux B. Onychomycosis and quality of life. Ann Dermatol Venereol, 2003, 130: 1275-1278.
2Drake L A, Scher R K, Smith E B, et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol, 1998, 38: 702-704.
3Baran R, Kaoukhov A. Topical antifungal drugs for the treat-ment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol, 2005, 19: 21-29.
4Robbins J M. Treatment of onychomycosis in the diabetic patient population. J Diabetes Complications, 2003,17 : 98- 104.
5Ralph R. Turner,Marcia A. Testa. Measuring the impact of onychomycosis on patient quality of life[J] 2000,Quality of Life Research(1):39～53
6D. P. Lubeck,D. Gause,J. R. Schein,L. E. Prebil,L. P. Potter. A health-related quality of life measure for use in patients with onychomycosis: a validation study[J] 1999,Quality of Life Research(1-2):121～129
7D. P. Lubeck,D. L. Patrick,P. McNulty,S. K. Fifer,J. Birnbaum. Quality of life of persons with onychomycosis[J] 1993,Quality of Life Research(5):341～348
